Bright Run funded projects

The PYNK program for young people diagnosed with breast cancer will help people under 40, who face a range of unique issues because of their age and the nature of their disease. “Breast cancer is particularly challenging for younger patients, with more aggressive...

BRIGHT Run has approved funding for a research project that aims to study the impact of a specialized type of radiation in patients with metastatic breast cancer. The project, headed by Dr. Elysia K. Donovan, a radiation oncologist at the Juravinski Cancer Centre aims...

BRIGHT provided funding to support a phase II randomized trial to evaluate the safety of two accelerated partial breast irradiation regimens, of different intensities, in women who had undergone lumpectomy for breast cancer. Sixty-two women were enrolled in Hamilton...

Hereditary breast cancer accounts for 5-10% of all breast cancer diagnoses and is primarily caused by changes (mutations) in two genes called BRCA1 and BRCA2. Female relatives found to carry a familial BRCA1/2 mutation are at high risk to develop breast and ovarian...

Imaging of the breast is an important tool in the early detection, diagnosis and monitoring of response to treatment in breast cancer. Mammography has been the gold standard for detection of breast cancer for many years. Mammographic findings are based on anatomic...